Difference between revisions of "Cisplatin (Platinol)"
Jump to navigation
Jump to search
(Created page with "Template to be used for chemotherapies: Mechanism *Platinum analog, alkylating-like *metabolism *excretion *CYP450 Dosing **Renal dose adjustments **Hepatic dose adjustments R...") |
|||
Line 4: | Line 4: | ||
*Platinum analog, alkylating-like | *Platinum analog, alkylating-like | ||
*metabolism | *metabolism | ||
− | * | + | *Excretion: renal ~90%, bile 10% |
− | *CYP450 | + | *CYP450: unknown |
Dosing | Dosing | ||
Line 11: | Line 11: | ||
**Hepatic dose adjustments | **Hepatic dose adjustments | ||
− | Routes of administration | + | Routes of administration: IV |
Side effects | Side effects | ||
**informed consent info | **informed consent info | ||
+ | **patient drug information | ||
[http://hemonc.org/index.php?title=Special:WhatLinksHere/Cisplatin List of regimens containing cisplatin] | [http://hemonc.org/index.php?title=Special:WhatLinksHere/Cisplatin List of regimens containing cisplatin] |
Revision as of 05:11, 12 November 2011
Template to be used for chemotherapies:
Mechanism
- Platinum analog, alkylating-like
- metabolism
- Excretion: renal ~90%, bile 10%
- CYP450: unknown
Dosing
- Renal dose adjustments
- Hepatic dose adjustments
Routes of administration: IV
Side effects
- informed consent info
- patient drug information
List of regimens containing cisplatin